PT623172E - Vacina de virus vaccinia recombinante do virus da doenca de marek - Google Patents
Vacina de virus vaccinia recombinante do virus da doenca de marekInfo
- Publication number
- PT623172E PT623172E PT93902962T PT93902962T PT623172E PT 623172 E PT623172 E PT 623172E PT 93902962 T PT93902962 T PT 93902962T PT 93902962 T PT93902962 T PT 93902962T PT 623172 E PT623172 E PT 623172E
- Authority
- PT
- Portugal
- Prior art keywords
- virus
- marek
- recombinant vaccinia
- disease
- disease virus
- Prior art date
Links
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 title abstract 2
- 241000700618 Vaccinia virus Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000700662 Fowlpox virus Species 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82007792A | 1992-01-13 | 1992-01-13 | |
US139193A | 1993-01-06 | 1993-01-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT623172E true PT623172E (pt) | 2005-02-28 |
Family
ID=26668976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT93902962T PT623172E (pt) | 1992-01-13 | 1993-01-07 | Vacina de virus vaccinia recombinante do virus da doenca de marek |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP0623172B1 (pt) |
JP (1) | JP3706130B2 (pt) |
AT (1) | ATE286137T1 (pt) |
AU (1) | AU680609B2 (pt) |
CA (1) | CA2127700C (pt) |
DE (1) | DE69333728T2 (pt) |
DK (1) | DK0623172T3 (pt) |
ES (1) | ES2236684T3 (pt) |
PT (1) | PT623172E (pt) |
WO (1) | WO1993014219A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6087127A (en) * | 1990-08-24 | 2000-07-11 | Board Of Trustees Operating Michigan State University | Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE |
US5756102A (en) * | 1990-11-20 | 1998-05-26 | Virogenetics Corporation | Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants |
US5925358A (en) * | 1993-02-26 | 1999-07-20 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
EP0696204A4 (en) * | 1993-02-26 | 1999-03-31 | Syntro Corp | Recombined chickenpox virus and its use |
US6136318A (en) * | 1993-02-26 | 2000-10-24 | Cochran; Mark D. | Recombinant fowlpox viruses and uses thereof |
AU2176997A (en) * | 1996-03-29 | 1997-10-22 | Nippon Zeon Co., Ltd. | Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use |
GB2460694A (en) * | 2008-06-06 | 2009-12-09 | Secr Defence | Attenuated poxviruses |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4603112A (en) * | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
AU605567B2 (en) * | 1987-03-11 | 1991-01-17 | Nippon Zeon Co., Ltd. | Recombinant avipoxvirus |
DE10399031I1 (de) * | 1987-08-28 | 2004-01-29 | Health Research Inc | Rekombinante Viren. |
FR2632863B2 (fr) * | 1987-10-29 | 1990-08-31 | Transgene Sa | Virus du fowlpox recombinant et vaccins derives de ces virus |
AU623913B2 (en) * | 1988-06-24 | 1992-05-28 | British Technology Group Limited | Fowlpox virus non-essential regions |
JP3339854B2 (ja) * | 1988-09-13 | 2002-10-28 | メリアル | ウイルスワクチン |
BE1004877A3 (fr) * | 1991-05-27 | 1993-02-16 | Solvay | Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus. |
DE69233080T2 (de) * | 1991-06-14 | 2004-04-15 | Connaught Technology Corp., Greenville | Rekombinanter hiv-spezifischer impfstoff aus poxviru |
US5369025A (en) * | 1991-06-28 | 1994-11-29 | The United States Of America As Represented By The Secretary Of Agriculture | Recombinant fowlpox vaccine for protection against Marek's disease |
-
1993
- 1993-01-07 AU AU34353/93A patent/AU680609B2/en not_active Expired
- 1993-01-07 EP EP93902962A patent/EP0623172B1/en not_active Expired - Lifetime
- 1993-01-07 ES ES93902962T patent/ES2236684T3/es not_active Expired - Lifetime
- 1993-01-07 AT AT93902962T patent/ATE286137T1/de active
- 1993-01-07 WO PCT/US1993/000084 patent/WO1993014219A1/en active IP Right Grant
- 1993-01-07 JP JP51254693A patent/JP3706130B2/ja not_active Expired - Lifetime
- 1993-01-07 CA CA002127700A patent/CA2127700C/en not_active Expired - Lifetime
- 1993-01-07 EP EP04017502A patent/EP1489165A1/en not_active Withdrawn
- 1993-01-07 DE DE69333728T patent/DE69333728T2/de not_active Expired - Lifetime
- 1993-01-07 PT PT93902962T patent/PT623172E/pt unknown
- 1993-01-07 DK DK93902962T patent/DK0623172T3/da active
Also Published As
Publication number | Publication date |
---|---|
DK0623172T3 (da) | 2005-04-25 |
DE69333728D1 (de) | 2005-02-03 |
CA2127700A1 (en) | 1993-07-22 |
JP3706130B2 (ja) | 2005-10-12 |
ES2236684T3 (es) | 2005-07-16 |
EP1489165A1 (en) | 2004-12-22 |
CA2127700C (en) | 2006-06-20 |
AU680609B2 (en) | 1997-08-07 |
EP0623172A1 (en) | 1994-11-09 |
AU3435393A (en) | 1993-08-03 |
ATE286137T1 (de) | 2005-01-15 |
JPH07503843A (ja) | 1995-04-27 |
EP0623172B1 (en) | 2004-12-29 |
DE69333728T2 (de) | 2006-08-31 |
WO1993014219A1 (en) | 1993-07-22 |
EP0623172A4 (en) | 1995-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT9019623A0 (it) | Sistema di selezione di spettro di infettivita' di poxvirus ricombinante | |
GB2269820A (en) | Flavivirus recombinant poxvirus vaccine | |
IT9020063A0 (it) | Vaccino di poxvirus ricombinante di herpesvirus | |
DK0592546T3 (da) | Immundeficiens-virus rekombinant poxvirus-vaccine | |
DE3853088D1 (de) | Rekombinantes Avipoxvirus. | |
DE68927025D1 (de) | HIV-2-Virusvarianten | |
DE69016956D1 (de) | Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor. | |
DK0523395T3 (da) | Seroreaktive områder på proteinerne E1 og E2 i HPV 16 | |
DE3888086D1 (de) | Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine. | |
DE3850019D1 (de) | Rekombinantes Avipoxvirus. | |
FR2620459B1 (fr) | Virus recombinant de la vaccine | |
EP0597016A4 (en) | Infectious bursal disease virus recombinant poxvirus vaccine. | |
DE69230627D1 (de) | Rekombinantes Avipoxvirus | |
GB2264949A (en) | Measles virus recombinant poxvirus vaccine | |
ATE117369T1 (de) | Rekombinantes virus der marekschen krankheit und vakzin. | |
NO974322L (no) | DNA som koder for human papillomvirus type 18 | |
PT652287E (pt) | Vectores de poxvirus e sua utilizacao contra doenca pelo virus da peritonite infecciosa felina | |
PT623172E (pt) | Vacina de virus vaccinia recombinante do virus da doenca de marek | |
EP0486106A3 (en) | Marek's disease virus vaccine | |
EP0759695A4 (en) | METHOD FOR INDUCING AN IMMUNE RESPONSE BY MEANS OF RECOMBINANT VACCINIA VIRUSES | |
AU7890687A (en) | DNA sequence vectors, recombinant viruses and method which employs recombinant vaccinia viruses capable of multiplying in CHO cells | |
NO881931L (no) | Stabil, lyofilisert, levende herpesvirusvaksine. | |
EP0496787A4 (en) | Novel infectious bursal disease virus | |
ATE165620T1 (de) | Impfstoffe auf basis geänderter boviner herpesviren typ 1 | |
AU2715288A (en) | Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein |